HDAC2 and acute myeloid leukemia: Moreover, we demonstrated significant differences in epigenetic-regulation-related gene expression: HDAC2 and TET1 gene expression was significantly higher, while GATAD2A and KAT6A was significantly lower in refractory AML patients compared to the responsive patients’ group (Figure 4).